The International Liver Congress 2018

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• The International Liver Congress convenes experts to discuss critical developments in liver disease research and clinical practice.
• Key areas of focus include viral hepatitis, metabolic dysfunction-associated steatohepatitis, and complex genetic disorders affecting the liver.

Purpose of the Study:

• To provide a comprehensive overview of significant findings and therapeutic updates from the International Liver Congress.
• To highlight advancements in the management of hepatitis C, primary biliary cholangitis, nonalcoholic steatohepatitis, homozygous familial hypercholesterolemia, and hepatocellular carcinoma.

Main Methods:

• Review of selected sessions and presentations from the International Liver Congress.
• Synthesis of key data and expert opinions on prevalent and emerging liver conditions.

Main Results:

• Summaries of recent progress in direct-acting antiviral therapies for hepatitis C.
• Updates on emerging treatment strategies for nonalcoholic steatohepatitis and its complications.
• Discussion of novel approaches for managing homozygous familial hypercholesterolemia and advanced hepatocellular carcinoma.

Conclusions:

• The International Liver Congress showcased significant progress across a spectrum of liver diseases.
• Continued research and clinical collaboration are vital for improving patient outcomes in hepatology.